Longitudinal characterization of chorioretinal atrophies after subretinal gene augmentation therapy with Voretigene Neparvovec in RPE65-mediated retinal degeneration - Research portal of Justus Liebig University Giessen:

Meeting Abstract

Longitudinal characterization of chorioretinal atrophies after subretinal gene augmentation therapy with Voretigene Neparvovec in RPE65-mediated retinal degeneration

Authors list: Kuenzel, Sandrine; Sassmannshausen, Marlene; Sassen, Josua; Preising, Markus; Holz, Frank; Lorenz, Birgit; Herrmann, Philipp

Publication year: 2023

Journal: Investigative Ophthalmology & Visual Science

Volume number: 64

Issue number: 8

ISSN: 0146-0404

eISSN: 1552-5783

Conference: Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology (ARVO)

Publisher: Association for Research in Vision and Ophthalmology

Citation Styles

Harvard Citation style: Kuenzel, S., Sassmannshausen, M., Sassen, J., Preising, M., Holz, F., Lorenz, B., et al. (2023) Longitudinal characterization of chorioretinal atrophies after subretinal gene augmentation therapy with Voretigene Neparvovec in RPE65-mediated retinal degeneration, Investigative Ophthalmology & Visual Science, 64(8), Article 5006

APA Citation style: Kuenzel, S., Sassmannshausen, M., Sassen, J., Preising, M., Holz, F., Lorenz, B., & Herrmann, P. (2023). Longitudinal characterization of chorioretinal atrophies after subretinal gene augmentation therapy with Voretigene Neparvovec in RPE65-mediated retinal degeneration. Investigative Ophthalmology & Visual Science. 64(8), Article 5006.